Design and analysis of structure-activity relationship of novel antimicrobial peptides derived from the conserved sequence of cecropin

Journal of Peptide Science

Volumn 14, Issue 3, 2008, Pages 290-298

  Hao, Gang ^a   Shi, Yong Hui ^a   Han, Jing Hiu ^a   Li, Qi Hui ^a   Tang, Ya Li ^a   Le, Guo Wei ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

Antimicrobial peptide; Bioinformatics; Design; Structure activity relationship

Indexed keywords

ANTIMICROBIAL PEPTIDE A; ANTIMICROBIAL PEPTIDE B; ANTIMICROBIAL PEPTIDE C; ANTIMICROBIAL PEPTIDE D; CECROPIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL STRAIN; BIOINFORMATICS; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG DESIGN; DRUG DETERMINATION; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MICELLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; BACTERIA; CECROPINS; CONSERVED SEQUENCE; DRUG DESIGN; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA;

EID: 40749132109     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.926     Document Type: Article

References (36)

1. Subbalakshmi C, Nagaraj R, Sitaram N. Biological activities of C-terminal 15-residue synthetic fragment of melittin: design of an analog with improved antibacterial activity. FEBS Lett. 1999; 448: 62-66.
2. Lee DG, Kim HN, Park Y, Kim HK, Choi BH, Choi CH, Hahm KS. Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1. Biochim. Biophys. Acta 2002; 1598: 185-194.
3. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395.
4. López-Garcia B, Ubhayasekera W, Gallo RL, Marcos JF. Parallel evaluation of antimicrobial peptides derived from the synthetic PAF26 and the human LL37. Biochem. Biophys. Res. Commun. 2007; 1016: 93-99.
5. Pál T, Sonnevend A, Galadari S, Conlon JM. Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2. Regul. Pept. 2005; 129: 85-91.
6. Krishnakumari V, Singh S, Nagaraj R. Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human β-defensins 1-3. Peptides 2006; 27: 2607-2613.
7. Pellegrini A, Fellenberg RV. Design of synthetic bactericidal peptides derived from the bactericidal domain P18-39 of aprotinin. Biochim Biophys. Acta. 1999; 1433: 122-131.
8. Chen HC, Brown JH, Morell JL, Huang CM. Synthetic magainin analogues with improved antimicrobial activity. FEBS Lett. 1988; 236: 462-466.
9. Yeaman MR Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003; 55: 27-55.
10. Hancock RE. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 2001; 1: 156-164.
11. Hancock RE, Chapple DS. Peptide, antibiotics. Antimicrob. Agents Chemother. 1999; 43: 1317-1323.
12. Matsuzaki K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta 1998; 1376: 391-400.
13. Sitaram N, Nagaraj R. Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. Biochim. Biophys. Acta 1999; 1462: 29-54.
14. Zhu WL, Lan HL, Park IS, Kim JI, Jin HZ, Halun KS, Shin SY. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide pep-1. Biochem. Biophys. Res. Commun. 2006; 349: 769-774.
15. Yang ST, Shin SY, Hahmb KS, Kim JI. Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities. Int. J. Antimicrob. Agents 2006; 27: 325-330.
16. Han JH. Study on Expression of Design Antimicrobial Peptides in E.coli and Antimicrobial Activity [D]. JiangNan University: Wuxi, 2006.
17. Fields GB, Noble RL. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 1990; 35: 161-214.
18. Chen Yh, Yang JT, Chau KH. Determination of the helix and beta form of proteins in aqueous solution by circular dichroism. Biochemistry 1974; 13: 3335-3350.
19. National Committee for Clinical Laboratory standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved standard M7-A4, 4th edn. NCCLS: Wayne, 1997.
20. Gobbo M, Bioni L, Filira F. Helix induction potential of N-terminal alpha-methyl, alpha-amino acids. Lett. Pept. Sci. 1998; 5: 105-107.
21. Tiozzo, E, Rocco G, Tossi A. Wide-spectrum antibiotic activity of synthetic, amphipathic peptides. Biochem. Biophys. Res. Commun. 1998; 249: 202-206.
22. Giangaspero A, Sandri L. Amphipathic alpha helical antimicrobial peptides-a systematic study of the effects of structural and physical properties on biological activity. Eur. J. Biochem. 2001; 268: 5589-5600.
23. Dickinson L, Russel V, Dunn PE. A family of bacteria-regulated, cecropin D-like peptides from Manduca sexta. J. Biol. Chem. 1988; 263: 19424-19429.
24. Oren Z, Shai Y. Mode of action of linear amphipathic a-helical antimicrobial peptides. Biopolymers 1998; 47: 451-463.
25. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by a-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1999; 1462: 55-70.
26. Tossi A, Sandri L, Giangaspero, A. Amphipathic a-helical antimicrobial peptides. Biopolymers 2000; 55: 4-30.
27. Boman HG. Antibacterial peptides: key components needed in immunity. Cell 1991: 65: 205-207.
28. Epand RM, Vogel HJ. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1999; 1462: 11-28.
29. Dathe M, Wieprecht T. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta 1999: 1462: 71-87.
30. Dathe M, Schumann M, Wieprecht T, Winkler A, Beyermann M, Krause E, Matsuzaki K, Murase O, Bienert M. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry 1996; 35: 12612-12622.
31. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta 1999; 1462: 1-10.
32. Fernandez LS, Kim HS, Choi EC. Antibacterial agents based on the cyclic D, L-alpha-peptide architecture. Nature 2001; 412: 452-455.
33. Sawyer JG, Martin NL, Hancock RE. Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect. Immun. 1988; 56: 693-698.
34. Takeuchi K, Takahashi H, Sugai M, Iwai H, Kohno T, Sekimizu K. Channel-forming membrane permeabflization by an antibacterial protein, sapecin: determination of membrane-buried and oligomerization surfaces by NMR. J. Biol. Chem. 2004; 279: 4981-4987.
35. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002; 66: 236-248.
36. Shin SY, Lee SH, Yang ST. Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. J. Pept. Res. 2001; 58: 504-514.